- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05322876
Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention
April 1, 2024 updated by: Gary J. Luckasen, MD, Poudre Valley Health System
The purpose of this study is to evaluate the feasibility of a 6-month family-based community intervention to mitigate cardiovascular disease risk factors in Hispanic families in northern Colorado as measured through biometric screenings, body composition, physical activity, and health knowledge.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The current project aims to leverage the UCHealth Healthy Hearts Family Program to provide a free, non-insurance-based 1-year cardiovascular disease (CVD) prevention and wellness program to Hispanic Colorado families.
This program includes an interactive educational class series, baseline and quarterly biometric screenings, and optional consultations with an Exercise Physiologist and a Dietitian.
This program takes a novel approach to preventative care by incorporating the family unit with the intention of having the child be the agent of change.
The long-term goals of this project are to significantly improve CVD risk factors among participating families and to disseminate study findings to inform developing and current outreach programs to offer effective CVD prevention programs for Hispanic citizens.
This work may ultimately lead to more Hispanics being served through new or existing programs, therefore expanding important preventative community health interventions into this underserved population.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Victoria M Bandera, MS
- Phone Number: 7329913081
- Email: victoria.bandera@uchealth.org
Study Contact Backup
- Name: NaNet Jenkins, MPH
- Phone Number: 9706245298
- Email: nanet.jenkins@uchealth.org
Study Locations
-
-
Colorado
-
Loveland, Colorado, United States, 80528
- Recruiting
- Medical Center of the Rockies
-
Contact:
- NaNet Jenkins, MPH, MHSA
- Phone Number: 970-624-5298
- Email: nanet.jenkins@uchealth.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- At least one member of the family unit self-identifies as Hispanic
- At least 13 years of age
Exclusion Criteria:
- Unwilling to wear Fitbit devices daily for 6 months except when charging and sleeping
- Cannot read or understand either English or Spanish
- Cannot return to screening location to perform the minimum of the baseline, 3-month and 6-month follow-up screenings
- Children or adolescents will be excluded from this project without a minimum of one accompanying parent or guardian
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Healthy Hearts Family Program
Participants will be enrolled in the standard Healthy Hearts Family Program 6-month family-based cardiovascular disease prevention program.
|
Participants will participate in a baseline health and knowledge screening, followed by a 6-week once-weekly class series, and 3- and 6-month follow-up health and knowledge screenings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of program through changes in physical health - Daily Steps
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Physical activity metrics (daily average steps per month) measured by Fitbit devices
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Physical Activity
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Physical activity metrics (daily minutes of light, moderate and vigorous activity per month) measured by Fitbit devices
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Blood Pressure
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Biometric variables (blood pressure in mmHg)
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Lab Value -Lipid Profile
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Biometric variables - lab values (lipid profile in mg/dL) measured through finger stick blood sampling
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Lab Value - Triglycerides
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Biometric variables - lab values ( triglycerides in mg/dL) measured through finger stick blood sampling
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Lab Value - Blood Glucose
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Biometric variables - lab values (blood glucose all in mg/dL) measured through finger stick blood sampling
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Waist Circumference
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Body composition (waist circumference in inches)
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Body Composition - Muscle Mass
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Body composition (muscle mass in pounds) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Body Composition - Fat Mass
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Body composition (fat-free mass in pounds) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Body Fat Percentage
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Body composition (body fat percentage) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in physical health - Visceral Fat Rating
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Body composition (Tanita visceral fat rating) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
|
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
|
Efficacy of program through changes in health knowledge
Time Frame: Baseline, post-6 week class series, 3- and 6-month follow-up appointments.
|
Health knowledge gained and retained will be evaluated and compared at baseline, post-6 week class series, 3- and 6-month follow-ups utilizing previously developed and utilized Healthy Hearts knowledge survey.
This outcome will be measured by correct responses on the Healthy Hearts knowledge survey.
|
Baseline, post-6 week class series, 3- and 6-month follow-up appointments.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adherence to program and utilization of additional resources - Program attendance - Percentage of Scheduled Visits Attended
Time Frame: These variables will be measured and assessed throughout the full 6 month program.
|
Attendance for screenings, classes and other consultations across baseline and follow-up visits.
Attendance will be measured as the percentage of scheduled visits (including the 6 week class series and the 3- and 6-month follow-up visits) completed.
|
These variables will be measured and assessed throughout the full 6 month program.
|
Adherence to program and utilization of additional resources - Fitbit Utilization
Time Frame: These variables will be measured and assessed throughout the full 6 month program.
|
Compliance to Fitbit utilization as measured by days worn throughout the 6 month program.
The NHANES compliance to wear time of > 10 hours worn per day will be utilized.
|
These variables will be measured and assessed throughout the full 6 month program.
|
Adherence to program and utilization of additional resources - Resource Utilization
Time Frame: These variables will be measured and assessed throughout the full 6 month program.
|
Use of Exercise Physiologist and Dietician resources provided will be quantified and reported.
This outcome will be reported as the number of consultation appointments requested and utilized throughout the program.
|
These variables will be measured and assessed throughout the full 6 month program.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Victoria Bandera, MS, University of Colorado Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 22, 2022
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2024
Study Registration Dates
First Submitted
February 25, 2022
First Submitted That Met QC Criteria
April 4, 2022
First Posted (Actual)
April 12, 2022
Study Record Updates
Last Update Posted (Actual)
April 3, 2024
Last Update Submitted That Met QC Criteria
April 1, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HHFP-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinActive, not recruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Healthy Hearts Family Program
-
Cornell UniversityTufts University; Montana State University; Bassett HealthcareCompletedObesity | Cardiovascular Disease | Overweight | Sedentary Lifestyle | Heart DiseaseUnited States
-
Michigan State UniversityCompletedStress | Pediatric Obesity | Healthy Diet | Intergenerational RelationsUnited States
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHypertension | Diabetes | Chronic Kidney Diseases | High Blood PressureUnited States
-
Oman Ministry of HealthSultan Qaboos UniversityRecruitingChildhood Obesity | Lifestyle, Healthy | Family | Behavior, HealthOman
-
Imperial College LondonEnrolling by invitationCardiovascular DiseasesUnited Kingdom
-
Duke UniversityFood and Drug Administration (FDA)RecruitingCongenital Heart DiseaseUnited States
-
Rutgers, The State University of New JerseyCompleted
-
Washington State UniversityRecruitingHypertensionUnited States
-
University of AarhusActive, not recruitingWeight Loss | Childhood Obesity | Health Behavior | Motivation
-
Social Insurance Institution, FinlandTurku University Hospital; University of TurkuCompletedADHD | Asperger Syndrome | Child Behavior DisordersFinland